Wemos in the media

Make medicines affordable – without going to court

Opinion by Tom Buis (Wemos) and Wilbert Bannenberg (Pharmaceutical Accountability Foundation) stating that governments can and must take control to prevent extreme drug prices.

Article - Politico - 11/7/2023

This minister does stand firm in negotiations on expensive medicines (in Dutch)

Tom Buis reacts in the FD to the news that Minister Ernst Kuipers said no to pharma companies asking very high prices for two new medicines.

Article - Het Financieele Dagblad - 16/4/2023

Health workers’ intra-EU migration causes headaches

A European Special Report on health workers' intra-EU migration, with stories from Poland, Bulgaria, Romania and Brussels.

Article - EURACTIVE - 17/3/2023

Lawsuit against pharmacist of most lucrative medicine: ‘High price violates human rights’ (in Dutch)

The Pharmaceutical Accountability Foundation sued pharmaceutical company Abbvie for the high prices of Humira, the world's most lucrative drug that helps rheumatoid arthritis, among other conditions.

Article - De Volkskrant - 21/2/2023

You cannot leave the distribution of healthcare personnel to the market (in Dutch)

While there is a shortage of healthcare workers all over Europe, the wealthier European countries are recruiting healthcare workers from other parts of Europe. Often leaving the countries of origin empty-handed.

Article - Vrij Nederland - 14/12/2022

Keep vaccine developer Intravacc in government hands (in Dutch)

Opinion article in newspaper NRC. With the announced sale of Intravacc, the Minister of Health is missing an opportunity to show how global access to vaccines can go hand in hand with financially sound operations.

Article - NRC - 25/8/2022

Netherlands: ensure that the pandemic disappears everywhere in the world (in Dutch)

Together with the directors of Aidsfonds, Artsen zonder Grenzen (MSF), Cordaid, ONE Campaign and Oxfam Novib, Wemos’ director Marielle Bemelmans plead the Dutch government in the newspaper Trouw to ensure vaccine equity.

Article - Trouw - 1/3/2022

A firstl: pharmaceutical company shares patent on corona pill with 105 low- and middle-income countries (in Dutch)

Article in De Volkskrant about pharmaceutical Merx sharing patent on virus-inhibiting corona pill with 105 low- and middle-income countries. With quotes by Tom Buis Wemos' global health advocate.

Article - De Volkskrant - 28/10/2021

A review says ACT-A should continue. Experts say changes are needed.

Devex interviewed our global health advocate Amanda Banda, who was selected as civil society representative for the health systems connector of the Access to Covid-19 Tools Accelerator (ACT-A), about the review of this global collaboration.

Article - Devex - 14/10/2021

Pharmaceutical companies must share knowledge around vaccines during pandemics (in Dutch)

Opinion article in newspaper Trouw on vaccine inequality and the role of Pharmaceutical companies.

Article - Trouw - 3/9/2021

Advocate sharing of patents, know-how, and technology to maximize vaccine production

Guest article by Ella Weggen & Marianne Meijer, Global Health Advocates at Wemos

Article - European Public Health Alliance - 8/7/2021

Dutch opposition to releasing patents for corona vaccines is based on persistent myths

Joint opinion piece with Oxfam Novib and Cordaid in De Volkskrant

Article - De Volkskrant - 21/6/2021

Fear of Wild West when patents are released unnecessary

Opinion article by Mariëlle Bemelmans in Financieele Dagblad.

Article - Het Financieele Dagblad - 21/5/2021

Secrecy in vaccine deals undermines public trust (in Dutch)

Opinion article in Trouw by Marianne Meijer, global health advocate at Wemos.

Article - Trouw - 8/1/2021